Vimarsana
Biggest News Aggregation in the World

Page 24 - Robin Yang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robin Yang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robin Yang Today - Breaking & Trending Today

Can Dental Therapists Ease the Dentist Shortage? - Vimarsana News

Can Dental Therapists Ease the Dentist Shortage?

Advocates say they can provide care, especially in underserved areas. Critics say there are easier solutions.

Source: wsj.com
QuantaSing Expands Global Presence with Acquisition of Kelly's Education - Vimarsana News

QuantaSing Expands Global Presence with Acquisition of Kelly's Education

BEIJING, Sept. 18, 2023 -- QuantaSing Group Limited , a leading online learning service provider in China, today announced its acquisition of Kelly's Education, an online language education...

QuantaSing Announces Unaudited Financial Results for the Fourth Quarter of Fiscal Year 2023 and Full Fiscal Year 2023 - Vimarsana News

QuantaSing Announces Unaudited Financial Results for the Fourth Quarter of Fiscal Year 2023 and Full Fiscal Year 2023

BEIJING, Sept. 15, 2023 -- QuantaSing Group Limited , a leading online learning service provider in China, today announced its fourth quarter and full year unaudited financial results for the...

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection - Vimarsana News

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

/PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection - Vimarsana News

YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection

GAITHERSBURG, Md., Sept. 15, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced that the United States Patent and Trademark Office has issued it a patent covering the...